Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?

Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?

Chronic respiratory disorders are the third leading cause of mortality globally. Consequently, there is a continuous pursuit of effective therapies beyond those currently available. The therapeutic potential of the glucagon-like peptide-1 (GLP-1) and the glucose-dependent insulinotropic polypeptide/...

Full description

Saved in:
Bibliographic Details
Main Authors: Miodrag Janić, Sabina Škrgat, Matevž Harlander, Mojca Lunder, Andrej Janež, Anca Pantea Stoian, Mohamed El-Tanani, Viviana Maggio, Manfredi Rizzo
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Medicina
Subjects:
respiratory disorders
GLP-1 receptor agonists
GIP/GLP-1 receptor agonists
asthma
COPD
Online Access:https://www.mdpi.com/1648-9144/60/12/2030
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1648-9144/60/12/2030

Similar Items